0001744333-25-000004.txt : 20251113 0001744333-25-000004.hdr.sgml : 20251113 20251113133709 ACCESSION NUMBER: 0001744333-25-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251113 DATE AS OF CHANGE: 20251113 EFFECTIVENESS DATE: 20251113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELIXIRGEN THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001744333 ORGANIZATION NAME: EIN: 830534578 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-563910 FILM NUMBER: 251477135 BUSINESS ADDRESS: STREET 1: 855 N. WOLFE ST. STREET 2: SUITE 624 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 443-451-5300 MAIL ADDRESS: STREET 1: 855 N. WOLFE ST. STREET 2: SUITE 624 CITY: BALTIMORE STATE: MD ZIP: 21205 D 1 primary_doc.xml X0708 D LIVE 0001744333 ELIXIRGEN THERAPEUTICS, INC. 855 N. WOLFE ST. SUITE 624 BALTIMORE MD MARYLAND 21205 443-451-5300 DELAWARE None None Corporation true AKIHIRO KO 855 N. WOLFE ST., SUITE 624 BALTIMORE MD MARYLAND 21205 Executive Officer Director HIROAKI KOBAYASHI 855 N. WOLFE ST., SUITE 624 BALTIMORE MD MARYLAND 21205 Director MINORU KO 855 N. WOLFE ST., SUITE 624 BALTIMORE MD MARYLAND 21205 Director THOMAS WHITE 855 N. WOLFE ST., SUITE 624 BALTIMORE MD MARYLAND 21205 Director SHAUNA CALLAHAN 855 N. WOLFE ST., SUITE 624 BALTIMORE MD MARYLAND 21205 Director JEFFREY CLELAND 855 N. WOLFE ST., SUITE 624 BALTIMORE MD MARYLAND 21205 Director Biotechnology Decline to Disclose 06b false 2025-10-30 false true true true false 0 4000000 4000000 0 false 1 0 0 0 false ELIXIRGEN THERAPEUTICS, INC. /s/ Akihiro Ko Akihiro Ko CEO 2025-11-13